Abstract
Objective Patients with Prader-Willi syndrome (PWS) is known to have bone fragility. Osteoporosis may be associated with bone fractures and poor surgical outcome for scoliosis. Current growth hormone (GH) treatment offers a viable and safe means to reduce these risks by improving bone density. The purposes of this study were to investigate bone mineral density (BMD) with PWS patients and to verify efficacy of growth hormone (GH) administration for osteoporosis.
Highlights
Osteoporosis may be associated with bone fractures and poor surgical outcome for scoliosis
Current growth hormone (GH) treatment offers a viable and safe means to reduce these risks by improving bone density
The purposes of this study were to investigate bone mineral density (BMD) with Prader-Willi syndrome (PWS) patients and to verify efficacy of growth hormone (GH) administration for osteoporosis
Summary
Objective Patients with Prader-Willi syndrome (PWS) is known to have bone fragility.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
